Pasithea Therapeutics Corp. (KTTAW) Revenue (2022)

Pasithea Therapeutics has disclosed Revenue across 1 years of filings, most recently posting $240712.0 for Q4 2022.

• In Q4 2022, Revenue changed N/A year-over-year to $240712.0; the TTM figure through Dec 2022 stood at $486559.0 (changed N/A YoY), while the FY2022 annual figure was $486559.0, up 3130.37% from the prior year.
• Revenue came in at $240712.0 for Q4 2022 at Pasithea Therapeutics, up from $218608.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $240712.0 in Q4 2022 to a low of $13581.0 in Q2 2022.